We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
ManpowerGroup
MAN
$2.63B
| $583K | ﹤0.01% |
5,912
-587
| -9% | -$52.2K |
|
|
EGRX
902
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $581K | ﹤0.01% |
8,500
-200
| -2% | -$15.2K |
|
903
Travere Therapeutics
TVTX
$5.74B
| $575K | ﹤0.01% |
19,400
-500
| -3% | -$14.3K |
|
904
TherapeuticsMD
TXMD
$24M
| $564K | ﹤0.01% |
1,750
-50
| -3% | -$15.3K |
|
|
IMGN
905
DELISTED
Immunogen Inc
IMGN
| $562K | ﹤0.01% |
55,100
-1,500
| -3% | -$14.4K |
|
906
Nu Skin
NUS
$250M
| $553K | ﹤0.01% |
6,938
| – | – |
|
907
Methanex
MEOH
$4.27B
| $550K | ﹤0.01% |
+7,500
| New | +$546K |
|
|
OPLN
908
Openlane
OPLN
$4.58B
| $539K | ﹤0.01% |
22,531
| – | – |
|
|
VER
909
DELISTED
VEREIT, Inc.
VER
| $537K | ﹤0.01% |
12,847
+2,681
| +26% | +$102K |
|
|
CATM
910
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $532K | ﹤0.01% |
14,838
| – | – |
|
911
SEI Investments
SEIC
$12.6B
| $526K | ﹤0.01% |
7,730
-7,487
| -49% | -$464K |
|
912
uniQure
QURE
$3.2B
| $520K | ﹤0.01% |
12,300
-300
| -2% | -$11.2K |
|
|
CSOD
913
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $516K | ﹤0.01% |
9,180
+8,230
| +866% | +$444K |
|
914
RenaissanceRe
RNR
$13.2B
| $515K | ﹤0.01% |
3,696
+1,637
| +80% | +$211K |
|
|
VG
915
DELISTED
Vonage Holdings Corporation
VG
| $514K | ﹤0.01% |
36,808
| – | – |
|
916
AXIS Capital
AXS
$7.43B
| $508K | ﹤0.01% |
8,464
+1,796
| +27% | +$102K |
|
917
Cable One
CABO
$203M
| $508K | ﹤0.01% |
605
-595
| -50% | -$473K |
|
918
Korn Ferry
KFY
$4.25B
| $507K | ﹤0.01% |
7,582
| – | – |
|
919
Trupanion
TRUP
$1.27B
| $507K | ﹤0.01% |
13,000
-9,000
| -41% | -$347K |
|
920
National Health Investors
NHI
$3.59B
| $504K | ﹤0.01% |
6,412
| – | – |
|
921
Halozyme
HALO
$12.2B
| $502K | ﹤0.01% |
27,500
-700
| -2% | -$12.3K |
|
922
Teledyne Technologies
TDY
$32B
| $502K | ﹤0.01% |
2,124
| – | – |
|
923
Macerich
MAC
$6.9B
| $499K | ﹤0.01% |
8,010
-115
| -1% | -$6.63K |
|
924
Kulicke & Soffa
KLIC
$4.53B
| $495K | ﹤0.01% |
19,126
| – | – |
|
925
Wolverine World Wide
WWW
$1.55B
| $494K | ﹤0.01% |
12,888
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.